Latvia vs Luxembourg: Proportion of bloodstream infection due to methicillin-resistant
Latvia
3.0%
in 2023
Luxembourg
4.7%
in 2022
Latvia rank
51st
Luxembourg rank
48th
Proportion of bloodstream infection due to methicillin-resistant over time
- Latvia
- Luxembourg
How they compare
Luxembourg currently reports 4.7% against 3.0% in Latvia, a difference of 1.7%.
That makes Luxembourg's figure about 1.6 times Latvia's.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Luxembourg ahead.
Latvia ranks 51st and Luxembourg ranks 48th of 55 countries.
Across the 2 decades both report, Latvia averaged higher in 1 and Luxembourg in 1.
Head to head by decade
| Decade | Latvia | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.6% | 7.8% | 1.2% | Luxembourg |
| 2020s | 7.3% | 4.4% | 2.9% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to methicillin-resistant, Latvia or Luxembourg?
- Luxembourg, at 4.7% against 3.0% in Latvia as of 2022.
- What is the difference in proportion of bloodstream infection due to methicillin-resistant between Latvia and Luxembourg?
- 1.7%, with Luxembourg ahead.
- How many years of comparable data are there for Latvia and Luxembourg?
- 6 years are reported by both, from 2017 to 2022.
- How do Latvia and Luxembourg rank globally for proportion of bloodstream infection due to methicillin-resistant?
- Latvia ranks 51st and Luxembourg ranks 48th of 55 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.